Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 464 for “"Leishmaniasis"”.

  1. Immunoendocrinological control of murine leishmaniasis

    … differences in susceptibility to visceral leishmaniasis were also observed in noncure BALB/c and cure C57BL/10 ScSn mice following L. donovani infection. In both strains male mice were relatively susceptible to L. donovani infection as compared with females.As no differences could be …

    strathclyde Repository record for Immunoendocrinological control of murine leishmaniasis (opens in a new tab)

  2. Arsenic, antimony and visceral leishmaniasis

    … compounds in the treatment of visceral leishmaniasis (VL) has declined from over 85% to less than 50%. This has been attributed to prolonged, widespread misuse of antimonials within the Indian private healthcare system. An alternative resistance hypothesis is that exposure to arsenic in …

    dundee Repository record for Arsenic, antimony and visceral leishmaniasis (opens in a new tab) Download PDF for Arsenic, antimony and visceral leishmaniasis (opens in a new tab)

  3. Epidemiological Study of Canine Leishmaniasis in Algeria and its Impact on the Human Visceral Leishmaniasis

    Zoonotic visceral leishmaniasis (VL), caused by Leishmania infantum is a vector-borne disease, transmitted to humans by the bite of infected female phlebotomine sand flies. In absence of treatment the outcome is death. The disease is characterised by irregular fever bouts, loss of weight, …

    liege Repository record for Epidemiological Study of Canine Leishmaniasis in Algeria and its Impact on the Human Visceral Leishmaniasis (opens in a new tab) Restricted access

  4. Development of a vaccine against leishmaniasis

    … by female sand flies, cause the disease leishmaniasis. Leishmaniasis is responsible for 25,000–65,000 deaths and 0.7–1.0 million new cases per year. At present, there is no clinical vaccine available. Previous studies have indicated that recombinant gamma glutamylcysteine synthetase …

    strathclyde Repository record for Development of a vaccine against leishmaniasis (opens in a new tab)

  5. Antibody Dependent Enhancement of Visceral Leishmaniasis

    Leishmaniasis is a parasitic disease caused by protozoans of the genus Leishmania. This vector-born disease, transmitted by biting phlebotomine sandflies, typically manifests in one of three ways. The cutaneous form of the disease is characterized by localized lesions of the skin and is by far the …

    central-wash Repository record for Antibody Dependent Enhancement of Visceral Leishmaniasis (opens in a new tab)

  6. Meta-Transcriptomic Profiling of Human Cutaneous Leishmaniasis

    … nature of the neglected tropical disease leishmaniasis, and of host-parasite interactions in general, remains incomplete. In this work, we used high throughput RNA-sequencing (RNA-seq) to analyze human host and Leishmania gene expression in cutaneous leishmaniasis patients. Skin biopsies …

    maryland Repository record for Meta-Transcriptomic Profiling of Human Cutaneous Leishmaniasis (opens in a new tab)

  7. New therapeutic strategies against trypanosomiasis and leishmaniasis

    Leishmaniasis and African Trypanosomiasis are diseases caused by the Kinetoplastida parasites of Leishmania sp. and Trypanosoma sp. respectively. Control and management of these diseases, which affect a significant number of people in the tropics and subtropical areas of the world, is beset with …

    glasgow Download PDF for New therapeutic strategies against trypanosomiasis and leishmaniasis (opens in a new tab)

  8. The haematological consequences of experimental visceral leishmaniasis

    Visceral leishmaniasis (VL) is a neglected tropical disease with high morbidity and mortality, presents with hepatosplenomegaly, immune dysregulation, haematological complications and high risk of co-/secondary infections. Thrombocytopenia is one of the predominant haematological features in …

    whiterose Download PDF for The haematological consequences of experimental visceral leishmaniasis (opens in a new tab)

  9. HEME DYSREGULATION LINKS HEMOGLOBINOPATHIES TO VISCERAL LEISHMANIASIS SUSCEPTIBILITY

    Visceral leishmaniasis (VL) is a lethal neglected tropical disease caused by Leishmania donovani, a parasite that cannot synthesize heme and must scavenge it from the host. How host heme status shapes infection outcome has remained poorly understood. Here we demonstrate that host heme availability …

    maryland Repository record for HEME DYSREGULATION LINKS HEMOGLOBINOPATHIES TO VISCERAL LEISHMANIASIS SUSCEPTIBILITY (opens in a new tab)

  10. The Influence of Parasite-derived Chemokines in Leishmaniasis

    Transgenic chemokine-secreting parasites were generated and used to actively recruit immune cells into Leishmania lesions. It was hypothesized that the chemokine induced cell migration would influence the magnitude and character of the immune response and thereby effect the outcome of disease. Two …

    maryland Repository record for The Influence of Parasite-derived Chemokines in Leishmaniasis (opens in a new tab)

  11. Study of Leishmaniasis as it occurs in India

    … of 10 cases of Kala azar, 1 case of cutaneous Leishmaniasis, and 64 cases of Oriental Sore are given. These are all cases which have been for some time under my personal care or observation. During my service at Chittagong, however, I had almost daily opportunity of seeing several fresh cases …

    edinburgh Repository record for Study of Leishmaniasis as it occurs in India (opens in a new tab)

  12. Marana: Leishmaniasis and the Pharmaceuticalization of War in Colombia

    … and a vector-borne disease called cutaneous leishmaniasis are inextricably connected and mutually constitutive. The stigmatization of the illness as the guerrilla disease is reinforced by the states restriction on access to antileishmanial medicines, a measure that is commonly interpreted as …

    york Repository record for Marana: Leishmaniasis and the Pharmaceuticalization of War in Colombia (opens in a new tab)

  13. Neutrophil interactions with Leishmania amastigotes: implications for chronic leishmaniasis

    Leishmaniasis is a neglected tropical disease responsible for considerable morbidity and mortality in the developing world. The immune response against Leishmania parasites must be fine-tuned to promote pathogen clearance without triggering excess inflammation, and this requires the concerted …

    utmb Repository record for Neutrophil interactions with Leishmania amastigotes: implications for chronic leishmaniasis (opens in a new tab)

  14. CD4+ T cells in the pathogenesis of visceral leishmaniasis

    Visceral leishmaniasis, caused by infection with the intracellular protozoan Leishmania donovani, is a chronic disease that affects the spleen, liver and bone marrow. Patients present with high parasite burdens in visceral organs, splenomegaly, cachexia, pancytopenia and will progress to death if …

    utmb Repository record for CD4+ T cells in the pathogenesis of visceral leishmaniasis (opens in a new tab)

  15. Regulation of immunity to cutaneous leishmaniasis by semaphorin 3E

    Cutaneous Leishmaniasis is a disease of man and animals caused by the protozoan parasite Leishmania. Leishmania major is one of the major causative agents of cutaneous leishmaniasis. The host factors that regulate resistance to Leishmania major are not completely known but are influenced by the …

    manitoba Repository record for Regulation of immunity to cutaneous leishmaniasis by semaphorin 3E (opens in a new tab)

  16. Studies on New Approaches to the Chemotherapy of Leishmaniasis

    … tested show potential for the treatment of leishmaniasis. Their use ensures that less drug is required, so overcoming the problems of drug toxicity associated with sodium stibogluconate. The efficacy of tubercidin in combination with inhibitors of nucleoside transport in mammalian cells, …

    glasgow Download PDF for Studies on New Approaches to the Chemotherapy of Leishmaniasis (opens in a new tab)

  17. Vaccination against experimental cutaneous leishmaniasis using attenuated Salmonella typhimurium

    … an oral vaccine against experimental cutaneous leishmaniasis in the susceptible BALB/c mouse. After 2 oral immunisations with GID101, lesion development was reduced following L. major infection. This vaccine therefore represents a considerable improvement over the previous attenuated S. …

    glasgow Repository record for Vaccination against experimental cutaneous leishmaniasis using attenuated Salmonella typhimurium (opens in a new tab) Download PDF for Vaccination against experimental cutaneous leishmaniasis using attenuated Salmonella typhimurium (opens in a new tab)

Page 1 of 24